{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:07:58Z","timestamp":1761718078924,"version":"3.37.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"801","license":[{"start":{"date-parts":[[1992,7,1]],"date-time":"1992-07-01T00:00:00Z","timestamp":709948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1992,7,1]]},"DOI":"10.1136\/pgmj.68.801.538","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T21:01:03Z","timestamp":1230584463000},"page":"538-543","source":"Crossref","is-referenced-by-count":11,"title":["Parkinson's disease"],"prefix":"10.1093","volume":"68","author":[{"given":"C D","family":"Marsden","sequence":"first","affiliation":[{"name":"University Department of Clinical Neurology, Institute of Neurology, The National Hospital for Neurology and Neurosurgry , Queen Square, London WC1N 3BG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1992,7,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn, M.M.; Yahr, M.D.","year":"1967","unstructured":"Hoehn, M.M. & Yahr, M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17: 427-442.","journal-title":"Neurology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntingdon","volume":"20","author":"true","year":"1973","unstructured":"Bernheimer, H., Birkmeyer, W., Hornykiewicz, 0. et al. Brain dopamine and the syndromes of Parkinson and Huntingdon. J Neurol Sci 1973, 20: 415-445.","journal-title":"J Neurol Sci"},{"issue":"18","key":"ref_3","first-page":"925","article-title":"Dopamine and brain function","volume":"1966","author":"Hornykiewicz, 0","unstructured":"Hornykiewicz, 0. Dopamine and brain function. Pharmacol Rev 1966, 18: 925-964.","journal-title":"Pharmacol Rev"},{"key":"ref_4","first-page":"166","article-title":"Biochemistry of neurotransmitters in Parkinson's disease","volume-title":"Movement Disorders 2","author":"Agid, Y.; Javoy-Agid, F.; Ruberg, M.","year":"1987","unstructured":"Agid, Y., Javoy-Agid, F. & Ruberg, M. Biochemistry of neurotransmitters in Parkinson's disease. In: Marsden, C.D. & Fahn, S. (eds) Movement Disorders 2. Butterworth, London, 1987, pp. 166-230."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM196702162760703","article-title":"Aromatic amino acids and modification ofparkinsonism","volume":"276","author":"Cotzias, G.C.; Van Woert, M.H.; Schiffer, L.M.","year":"1967","unstructured":"Cotzias, G.C., Van Woert, M.H. & Schiffer, L.M. Aromatic amino acids and modification ofparkinsonism. NEngl JMed 1967, 276: 374-378.","journal-title":"NEngl JMed"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(77)91146-1","article-title":"Success and problems of long-term levodopa therapy in Parkinson's disease","volume":"1","author":"Marsden, C.D.; Parkes, J.D.","year":"1977","unstructured":"Marsden, C.D. & Parkes, J.D. Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet 1977, 1: 345-349.","journal-title":"Lancet"},{"key":"ref_7","first-page":"535","article-title":"L-dopa treatment and Parkinson's disease","volume":"59","author":"Lees, A.J.","year":"1986","unstructured":"Lees, A.J. L-dopa treatment and Parkinson's disease. Q J Med 1986, 59: 535-547.","journal-title":"Q J Med"},{"issue":"1","key":"ref_8","first-page":"292","article-title":"On-off effects in patients with Parkinson's disease on chronic levodopa therapy","volume":"1976","author":"Marsden, C.D.; Parkes, J.D.","unstructured":"Marsden, C.D. & Parkes, J.D. On-off effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet, 1976, 1: 292-296.","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJM198402233100802","article-title":"The on-off phenomenon in Parkinson's disease","volume":"310","author":"Nutt, J.G.; Woodward, W.R.; Hammerstad, J.P.; Carter, J.P.; Anderson, J.L.","year":"1984","unstructured":"Nutt, J.G., Woodward, W.R., Hammerstad, J.P., Carter, J.P. & Anderson, J.L. The on-off phenomenon in Parkinson's disease. N Engl J Med 1984, 310: 483-488.","journal-title":"N Engl J Med"},{"issue":"34","key":"ref_10","first-page":"1131","article-title":"Control of on\/off phenomenon by continuous intravenous infusion of levodopa","volume":"1984","author":"Quinn, N.; Parkes, J.D.; Marsden, C.D.","unstructured":"Quinn, N., Parkes, J.D. & Marsden, C.D. Control of on\/off phenomenon by continuous intravenous infusion of levodopa. Neurology 1984, 34: 1131-1136.","journal-title":"Neurology"},{"issue":"1","key":"ref_11","first-page":"467","article-title":"Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease","volume":"1986","author":"Obeso, J.A.; Luquin, M.R.; Martinez-Lage, J.M.","unstructured":"Obeso, J.A., Luquin, M.R. & Martinez-Lage, J.M. Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease. Lancet 1986, 1: 467-470.","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jnnp.53.2.96","article-title":"Subcutaneous apomorphine in the treatment of Parkinson's disease","volume":"53","author":"Frankel, J.P.; Lees, A.J.; Kempster, P.A.; Stem, G.M.","year":"1990","unstructured":"Frankel, J.P., Lees, A.J., Kempster, P.A. & Stem, G.M. Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiat 1990, 53: 96-101.","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mds.870040204","article-title":"The antiparkinsonian actions and pharmacokinetics of transdermal (+ )-4-propyl-9-hydroxynapthoxazine (PHNO): preliminary results","volume":"4","author":"Coleman, R.J.; Lange, K.W.; Quinn, N.P.","year":"1989","unstructured":"Coleman, R.J., Lange, K.W., Quinn, N.P. et al. The antiparkinsonian actions and pharmacokinetics of transdermal (+ )-4-propyl-9-hydroxynapthoxazine (PHNO): preliminary results. Movement Disord 1989, 4: 129-138.","journal-title":"Movement Disord"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1056\/NEJM198704023161402","article-title":"Open microsurgical autograft of adrenal medulia to the right caudate nucleus in two patients with intractable Parkinson's disease","volume":"316","author":"Madrazo, I.; Drucker-Colin, R.; Diaz, V.; Martinez-Mata, J.; Torres, C.; Becerill, J.J.","year":"1987","unstructured":"Madrazo, I., Drucker-Colin, R., Diaz, V., Martinez-Mata, J., Torres, C. & Becerill, J.J. Open microsurgical autograft of adrenal medulia to the right caudate nucleus in two patients with intractable Parkinson's disease. NEnglJMed 1987, 316: 831-834.","journal-title":"NEnglJMed"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1126\/science.2105529","article-title":"Grafts of foetal dopamine neurons survive and improve motor function in Parkinson's disease","volume":"247","author":"Lindvall, O.; Brundin, P.; Widner, H.","year":"1990","unstructured":"Lindvall, O., Brundin, P., Widner, H. et al. Grafts of foetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990, 247: 574-577.","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/WNL.33.7.815","article-title":"Parkinson's disease in 65 pairs of twins and in a set of quadruplets","volume":"33","author":"Ward, C.D.; Duvoisin, R.C.; Ince, S.E.; Nutt, J.D.; Eldridge, R.; Calne, D.B.","year":"1983","unstructured":"Ward, C.D., Duvoisin, R.C., Ince, S.E., Nutt, J.D., Eldridge, R. & Calne, D.B. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 1983, 33: 815-824.","journal-title":"Neurology"},{"issue":"35","key":"ref_17","first-page":"949","article-title":"Permanent human parkinsonism due to MPTP","volume":"1985","author":"Ballard, P.A.; Tetrud, J.W.; Langston, J.W.","unstructured":"Ballard, P.A., Tetrud, J.W. & Langston, J.W. Permanent human parkinsonism due to MPTP. Neurology 1985, 35: 949-956.","journal-title":"Neurology"},{"issue":"120","key":"ref_18","first-page":"574","article-title":"Metabolism of the neurotoxic tertiary amine, MPIP, by brain monoamine oxidase","volume":"1984","author":"Chiba, K.; Trevor, A.; Castagnoli, N.","unstructured":"Chiba, K., Trevor, A. & Castagnoli, N. Metabolism of the neurotoxic tertiary amine, MPIP, by brain monoamine oxidase. Biochem Biophys Res Commun 1984, 120: 574-578.","journal-title":"Biochem Biophys Res Commun"},{"issue":"82","key":"ref_19","first-page":"2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4phenyl-1,2,3,6-tetrahydropyridine. Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons","volume-title":"explains selective toxicity. Proc Nati Acad Sci USA","volume":"1985","author":"Javitch, J.A.; D'Amato, R.J.; Strittmatter, S.M.; Snyder, S.H.","unstructured":"Javitch, J.A., D'Amato, R.J., Strittmatter, S.M. & Snyder, S.H. Parkinsonism-inducing neurotoxin, N-methyl-4phenyl-1,2,3,6-tetrahydropyridine. Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Nati Acad Sci USA 1985, 82: 2173-2177."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1471-4159.1987.tb04142.x","article-title":"Characterisation of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4phenyl-1,2,3,6-tetrahydropyridine to neuromelanin","volume":"48","author":"D'Amato, R.J.; Benham, D.F.; Snyder, S.H.","year":"1987","unstructured":"D'Amato, R.J., Benham, D.F. & Snyder, S.H. Characterisation of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4phenyl-1,2,3,6-tetrahydropyridine to neuromelanin. J Neurochem 1987, 48: 653-658.","journal-title":"J Neurochem"},{"issue":"46","key":"ref_21","first-page":"1501","article-title":"Studies on the neurotoxicity of I -methyl4-phenyl-1,2,3,6-tetrahydropyridine. Inhibition ofNAD-linked substrate oxidation by its metabolite l-methyl-4-phenylpyridinium","volume":"1986","author":"Vyas, I.; Heikkila, R.E.; Nicklas, W.J.","unstructured":"Vyas, I., Heikkila, R.E. & Nicklas, W.J. Studies on the neurotoxicity of I -methyl4-phenyl-1,2,3,6-tetrahydropyridine. Inhibition ofNAD-linked substrate oxidation by its metabolite l-methyl-4-phenylpyridinium. JNeurochem 1986, 46: 1501-1507.","journal-title":"JNeurochem"},{"issue":"37","key":"ref_22","first-page":"4573","article-title":"l-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPIP) and free radicals in vitro","volume":"1988","author":"Rossetti, Z.L.; Sotgiu, A.; Sharp, D.; Hadjiconstantinou, M.; Neff, N.H.","unstructured":"Rossetti, Z.L., Sotgiu, A., Sharp, D., Hadjiconstantinou, M. & Neff, N.H. l-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPIP) and free radicals in vitro. Biochem Pharmacol 1988, 37: 4573-4574.","journal-title":"Biochem Pharmacol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410260518","article-title":"Deprenyl suppresses the oxidant stress associated with increased dopamine turnover","volume":"26","author":"Cohen, G.; Spina, M.B.","year":"1989","unstructured":"Cohen, G. & Spina, M.B. Deprenyl suppresses the oxidant stress associated with increased dopamine turnover. Ann Neurol 1989, 26: 689-690.","journal-title":"Ann Neurol"},{"key":"ref_24","first-page":"9168","article-title":"Structural dependence of the inhibition of mitochondrial respiration and of NADH oxidase by MPP+ analogs and their energised","volume-title":"accumulation of mitochondria. Proc Natl Acad Sci","volume":"86","author":"Ramsay, R.R.; Youngster, S.K.; Nicklas, W.J.","year":"1989","unstructured":"Ramsay, R.R., Youngster, S.K., Nicklas, W.J. et al. Structural dependence of the inhibition of mitochondrial respiration and of NADH oxidase by MPP+ analogs and their energised accumulation of mitochondria. Proc Natl Acad Sci USA 1989, 86: 9168-9172."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/0006-291X(90)90396-5","article-title":"4'-Akylated analogs of MPP+ are potent inhibitors of mitochondrial respiration","volume":"169","author":"Youngster, S.K.; Gluck, M.R.; Heikkila, R.E.; Nicklas, W.J.","year":"1990","unstructured":"Youngster, S.K., Gluck, M.R., Heikkila, R.E. & Nicklas, W.J. 4'-Akylated analogs of MPP+ are potent inhibitors of mitochondrial respiration. Biochem Biophys Res Commun 1990, 169: 758-764.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0166-2236(89)90135-5","article-title":"The role ofenvironmental toxins in the etiology of Parkinson's disease","volume":"12","author":"Tanner, C.M.","year":"1989","unstructured":"Tanner, C.M. The role ofenvironmental toxins in the etiology of Parkinson's disease. Trends Neurosci 1989, 12: 49-54.","journal-title":"Trends Neurosci"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/WNL.39.7.883","article-title":"Xenobiotic metabolism in Parkinson's disease","volume":"39","author":"Steventon, G.B.; Heafield, H.T.E.; Waring, R.H.; Williams, A.C.","year":"1989","unstructured":"Steventon, G.B., Heafield, H.T.E., Waring, R.H. & Williams, A.C. Xenobiotic metabolism in Parkinson's disease. Neurology 1989, 39: 883-887.","journal-title":"Neurology"},{"key":"ref_28","first-page":"356","volume":"i:","author":"Waring, R.H.; Sturman, S.G.; Smith, M.C.G.","year":"1989","unstructured":"Waring, R.H., Sturman, S.G., Smith, M.C.G. et al. Smethylation in motor neuron disease and Parkinson's disease. Lancet 1989, i: 356-357.","journal-title":"et al. Smethylation in motor neuron disease and Parkinson's disease. Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mds.870050302","article-title":"Twin studies and the genetics of Parkinson's disease-a reappraisal","volume":"5","author":"Johnson, W.G.; Hodge, S.E.; Duvoisin, R.","year":"1990","unstructured":"Johnson, W.G., Hodge, S.E. & Duvoisin, R. Twin studies and the genetics of Parkinson's disease-a reappraisal. Movement Disord 1990, 5: 187-194.","journal-title":"Movement Disord"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.410270309","article-title":"A large kindred with autosomal dominant Parkinson's disease","volume":"27","author":"Golbe, L.I.; Di Iorio, G.; Bonavita, V.; Miller, D.C.; Duvoisin, R.C.","year":"1990","unstructured":"Golbe, L.I., Di Iorio, G., Bonavita, V., Miller, D.C. & Duvoisin, R.C. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 1990, 27: 276-282.","journal-title":"Ann Neurol"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/mds.870060303","article-title":"A clinical and genetic study of familial Parkinson's disease","volume":"6","author":"Maraganore, D.M.; Harding, A.E.; Marsden, C.D.","year":"1991","unstructured":"Maraganore, D.M., Harding, A.E. & Marsden, C.D. A clinical and genetic study of familial Parkinson's disease. Movement Disord 1991, 6: 205-211.","journal-title":"Movement Disord"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham, D.G.","year":"1978","unstructured":"Graham, D.G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 1978, 14: 633-643.","journal-title":"Mol Pharmacol"},{"key":"ref_33","article-title":"Oxygen radicals and Parkinson's disease","volume-title":"Oxygen Radicals, and Tissue Injury. Federation of American Societies for Experimental Biology","author":"Cohen, G.","year":"1987","unstructured":"Cohen, G. Oxygen radicals and Parkinson's disease. In: Halliwell, B. (ed) Oxygen Radicals, and Tissue Injury. Federation of American Societies for Experimental Biology, Bethesda, 1987."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0091-3057(84)90125-4","article-title":"Formation of6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine","volume":"21","author":"Seiden, L.S.; Vosmer, G.","year":"1984","unstructured":"Seiden, L.S. & Vosmer, G. Formation of6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacol Biochem Behav 1984, 21: 29-31.","journal-title":"Pharmacol Biochem Behav"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","article-title":"Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease","volume":"52","author":"Dexter, D.T.; Carter, C.J.; Wells, F.R.","year":"1989","unstructured":"Dexter, D.T., Carter, C.J., Wells, F.R. et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989, 52: 381-389.","journal-title":"J Neurochem"},{"key":"ref_36","article-title":"Increased levels of lipid hydroperoxides but no evidence for increased free radical formation in the parkinsonian substantia nigra","author":"Dexter, D.T.; Holley, A.E.; Flitter, W.D.","year":"1992","unstructured":"Dexter, D.T., Holley, A.E., Flitter, W.D. et al. Increased levels of lipid hydroperoxides but no evidence for increased free radical formation in the parkinsonian substantia nigra. J Neurochem 1992 (in press).","journal-title":"J Neurochem"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1471-4159.1989.tb11759.x","article-title":"A selective increase in particulate superoxide dismutase activity in Parkinsoniansubstantia nigra","volume":"53","author":"Saggu, H.; Cooksey, J.; Dexter, D.","year":"1989","unstructured":"Saggu, H., Cooksey, J., Dexter, D. et al. A selective increase in particulate superoxide dismutase activity in Parkinsoniansubstantia nigra. J Neurochem 1989, 53: 692-697.","journal-title":"J Neurochem"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","article-title":"Parkinson's disease: A disorder due to nigral glutathione deficiency?","volume":"33","author":"Perry, T.L.; Godin, D.V.; Hansen, S.","year":"1982","unstructured":"Perry, T.L., Godin, D.V. & Hansen, S. Parkinson's disease: A disorder due to nigral glutathione deficiency? Neurosci Lett 1982, 33: 305-310.","journal-title":"Neurosci Lett"},{"key":"ref_39","first-page":"219","article-title":"Increased nigral iron content in post-mortem parkinsonian brain","volume":"ii:","author":"Dexter, D.T.; Wells, F.R.; Agid, F.","year":"1987","unstructured":"Dexter, D.T., Wells, F.R., Agid, F. et al. Increased nigral iron content in post-mortem parkinsonian brain. Lancet 1987, ii: 219-220.","journal-title":"Lancet"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","article-title":"Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains","volume":"52","author":"Riederer, P.; Sofic, E.; Rausch, W.-D.","year":"1989","unstructured":"Riederer, P., Sofic, E., Rausch, W.-D. et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 1989, 52: 515-520.","journal-title":"J Neurochem"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","article-title":"Alterations in the levels of iron and ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia","volume":"114","author":"Dexter, D.T.; Carayon, A.; Javoy-Agid, F.","year":"1991","unstructured":"Dexter, D.T., Carayon, A., Javoy-Agid, F. et al. Alterations in the levels of iron and ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991, 114: 1953-1975.","journal-title":"Brain"},{"key":"ref_42","first-page":"1269","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"1","author":"Schapira, A.H.V.; Cooper, J.M.; Dexter, D.; Jenner, P.; Clark, J.B.; Marsden, C.D.","year":"1989","unstructured":"Schapira, A.H.V., Cooper, J.M., Dexter, D., Jenner, P., Clark, J.B. & Marsden, C.D. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989, 1: 1269.","journal-title":"Lancet"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira, A.H.V.; Cooper, J.M.; Dexter, D.; Clark, J.B.; Jenner, P.; Marsden, C.D.","year":"1990","unstructured":"Schapira, A.H.V., Cooper, J.M., Dexter, D., Clark, J.B., Jenner, P. & Marsden, C.D. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990, 54: 823-827.","journal-title":"J Neurochem"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","article-title":"Anatomic and disease specificity of NADH CoQ reductase (complex 1) deficiency in Parkinson's disease","volume":"55","author":"Schapira, A.H.V.; Mann, V.M.; Cooper, J.M.","year":"1990","unstructured":"Schapira, A.H.V., Mann, V.M., Cooper, J.M. et al. Anatomic and disease specificity of NADH CoQ reductase (complex 1) deficiency in Parkinson's disease. J Neurochem 1990, 55: 2142-2145.","journal-title":"J Neurochem"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1056\/NEJM198911163212004","article-title":"Effect of deprenyl on the progression of disability in early Parkinson's disease","volume":"321","author":"Group, Parkinson Study","year":"1989","unstructured":"Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engi J Med 1989, 321: 1364-1371.","journal-title":"N Engi J Med"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/68\/801\/538\/50074329\/postgradmedj-68-538.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/68\/801\/538\/50074329\/postgradmedj-68-538.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T15:42:51Z","timestamp":1738856571000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/68\/801\/538\/7062393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,7,1]]},"references-count":45,"journal-issue":{"issue":"801","published-online":{"date-parts":[[1992,7,1]]},"published-print":{"date-parts":[[1992,7,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.68.801.538","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"type":"print","value":"0032-5473"},{"type":"electronic","value":"1469-0756"}],"subject":[],"published-other":{"date-parts":[[1992,7]]},"published":{"date-parts":[[1992,7,1]]}}}